Trial intelligence / Profile preview

Nebulized ketamine for acute asthma attack

IRCT2015052922468N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of ketamine in asthma, sponsored by Iran University of Medical Sciences. Started Aug 2014; status: completed.

02

Drugs

ketamine
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT2015052922468N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015052922468N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call